Radiolabeling and Analysis of Labeled Proteins

  • Nicole Berndt
  • Ralf Bergmann
  • Michael BachmannEmail author
Part of the Methods in Molecular Biology book series (MIMB, volume 1853)


Protein-based preparations for biomedical research, and radiolabeled pharmaceuticals for nuclear medical diagnostics and therapy require highest chemical, radiochemical, and in particular protein purity. For detection of contaminations most commonly size exclusion high-performance liquid chromatography and polyacrylamide gel analysis in combination with silver staining is used. Here we describe a by far more sensitive radiolabeling method for the detection of traces of contaminating proteins.

Key words

Autoradiography Polyacrylamide gel Proteins 


  1. 1.
    Albert S, Arndt C, Feldmann A, Bergmann R, Bachmann D, Koristka S, Ludwig F, Ziller-Walter P, Kegler A, Gärtner S, Schmitz M, Ehninger A, Cartellieri M, Ehninger G, Pietzsch J, Steinbach J, Bachmann M (2017) A novel nanobody-based target module for retargeting of T lymphocytes to EGFR-expressing cancer cells via the modular UniCAR platform. Oncoimmunol.
  2. 2.
    Szelecsényi F, Blessing G, Qaim SM (1993) Excitation functions of proton induced nuclear reactions on enriched 61Ni and 64Ni: possibility of production of no-carrier-added 61Cu and 64Cu at a small cyclotron. Appl Radiat Isot 44:575–580CrossRefGoogle Scholar
  3. 3.
    McCarthy DW, Shefer RE, Klinkowstein RE, Bass LA, Margeneau WH, Cutler CS et al (1997) Efficient production of high specific activity 64Cu using a biomedical cyclotron. Nucl Med Biol 24:35–43CrossRefPubMedGoogle Scholar
  4. 4.
    Thieme S, Walther M, Pietzsch H-J, Henniger J, Preusche S, Maeding P, Steinbach J (2012) Module-assisted preparation of 64Cu with high specific activity. Appl Radiat Isot 70:602–608CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Nicole Berndt
    • 1
  • Ralf Bergmann
    • 1
  • Michael Bachmann
    • 1
    Email author
  1. 1.Institute of Radiopharmaceutical Cancer Research, Radioimmunology, Helmholtz-Zentrum Dresden-Rossendorf e.V.(HZDR)DresdenGermany

Personalised recommendations